Sands Capital Life Sciences Pulse Fund II, L.P.

Holdings History for Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Symbol
ACRV on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Shares Owned
2,122,605 shares
Security Ownership %
6.8%

Sands Capital Life Sciences Pulse Fund II, L.P. ownership in Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV)

13 Aug 2025 - Sands Capital Life Sciences Pulse Fund II, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,122,605 shares of Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV). This represents 6.8% ownership of the company. This is the first filing by Sands Capital Life Sciences Pulse Fund II, L.P. disclosing ownership of Acrivon Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Shares") (ACRV).